222 related articles for article (PubMed ID: 23568763)
1. Daidzein, R-(+)equol and S-(-)equol inhibit the invasion of MDA-MB-231 breast cancer cells potentially via the down-regulation of matrix metalloproteinase-2.
Magee PJ; Allsopp P; Samaletdin A; Rowland IR
Eur J Nutr; 2014 Feb; 53(1):345-50. PubMed ID: 23568763
[TBL] [Abstract][Full Text] [Related]
2. The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.
Rigalli JP; Scholz PN; Tocchetti GN; Ruiz ML; Weiss J
Eur J Nutr; 2019 Feb; 58(1):139-150. PubMed ID: 29101532
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 inhibits expression and activities of matrix metalloproteinase-2 and -9 in human uterine fibroid cells.
Halder SK; Osteen KG; Al-Hendy A
Hum Reprod; 2013 Sep; 28(9):2407-16. PubMed ID: 23814095
[TBL] [Abstract][Full Text] [Related]
5. Regulation of mRNAs encoding MMP-9 and MMP-2, and their inhibitors TIMP-1 and TIMP-2 by androgens in the rat ventral prostate.
Limaye AM; Desai KV; Chavalmane AK; Kondaiah P
Mol Cell Endocrinol; 2008 Nov; 294(1-2):10-8. PubMed ID: 18675881
[TBL] [Abstract][Full Text] [Related]
6. The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
de la Parra C; Otero-Franqui E; Martinez-Montemayor M; Dharmawardhane S
J Biol Chem; 2012 Dec; 287(50):41640-50. PubMed ID: 23095751
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
9. Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.
Yan L; Lin B; Gao L; Gao S; Liu C; Wang C; Wang Y; Zhang S; Iwamori M
Int J Mol Sci; 2010 Nov; 11(11):4441-52. PubMed ID: 21151448
[TBL] [Abstract][Full Text] [Related]
10. Gene Expression of Matrix Metalloproteinases and their Inhibitors (TIMPs) in Meningiomas of Dogs.
Mandara MT; Reginato A; Foiani G; De Luca S; Guelfi G
J Vet Intern Med; 2017 Nov; 31(6):1816-1821. PubMed ID: 28875568
[TBL] [Abstract][Full Text] [Related]
11. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
12. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
13. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ; Li DQ; Hou YF; Wu J; Lu JS; Di GH; Jin W; Ou ZL; Shen ZZ; Shao ZM
Breast Cancer Res; 2007; 9(6):R76. PubMed ID: 17980029
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas.
Zhang X; Wang Y; Yamamoto G; Tachikawa T
Histopathology; 2009 Sep; 55(3):250-60. PubMed ID: 19723139
[TBL] [Abstract][Full Text] [Related]
16. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
17. Suppression of human breast cancer cell metastasis by coptisine in vitro.
Li J; Qiu DM; Chen SH; Cao SP; Xia XL
Asian Pac J Cancer Prev; 2014; 15(14):5747-51. PubMed ID: 25081696
[TBL] [Abstract][Full Text] [Related]
18. Formononetin inhibits migration and invasion of MDA-MB-231 and 4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through PI3K/AKT signaling pathways.
Zhou R; Xu L; Ye M; Liao M; Du H; Chen H
Horm Metab Res; 2014 Oct; 46(11):753-60. PubMed ID: 24977660
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
20. [Expression and clinical significance of MMP-2, MMP-9,TIMP-1, and TIMP-2 in breast carcinoma].
Fan SQ; Wei QY; Li MR; Zhang LQ; Liang QC
Ai Zheng; 2003 Sep; 22(9):968-73. PubMed ID: 12969531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
